CBC News – Rexall pharmacy chain sold to U #map #pharma

Posted On Nov 18 2017 by

#rexall pharma plus # Rexall pharmacy chain sold to U.S. health firm McKesson in $3B deal Video Canadian drug store chain Rexall is set to be bought by U.S. health-services company McKesson Corp. in a $3 billion deal. The Edmonton-based chain of 470 pharmacies announced the deal, in a release on Wednesday, that will see the company move to the hands of San Francisco-based McKesson, but keep operating under the names Rexall and Pharmaplus in Canada. The deal is expected to close in the first half of 2016, but will require numerous levels of regulatory and shareholder approval including the …


WELCOME TO WJPR #www.pharma.com

Posted On Nov 17 2017 by

#pharmaceutical research # World Journal of Pharmaceutical Research (WJPR) has indexed with various reputed international bodies like. Index Copernicus. Google Scholar. EBSCO Publishing Inc (Academic Search Complete), USA. Indian Science Publications. Urlich’s Periodicals Directory, Proquest, UK. NewJour-Georgetown University Library, USA. SOCOLAR, China. eGranary Digital Library, USA. CAS (A Division of American Chemical Society) USA. Research Bible, Fuchu, Tokyo. JAPAN. Science Central, USA. Kaohsiung Medical University Library, CHINA. VIKAS PSOAR (Pharmaceutical Sciences Open Access Resources). Scopus ((Elsevier Products in process). EMBASE (Elsevier Products, in process). Directory of Open Access Journal (DOAJ, Sweden, in process). Thomson Reuters, USA (in process). Genamics JournalSeek …


Valeant to buy orphan drug developer Aton for $318M #china #pharma

Posted On Nov 17 2017 by

#aton pharma # Valeant to buy orphan drug developer Aton for $318M Valeant Pharmaceuticals is continuing an aggressive buying spree, announcing this morning that it has sealed a deal to buy orphan drugmaker Aton Pharma for $318 million. Aton sells as well as develops therapies for orphan diseases and is expected to reap $80 million to $100 million in revenue for this year. “The acquisition of Aton fits into our long-term strategy to pursue diversified opportunities within the pharmaceutical market and offers us another platform for future growth,” said J. Michael Pearson, chairman and CEO. “With a business that has …


Endo to slash 740 jobs at AL, NC sites #pharmaceutical #sales

Posted On Nov 16 2017 by

#pharmaceutical companies in charlotte nc # Endo to slash 740 jobs at AL, NC sites Suffering from several “previously unanticipated headwinds,” Endo is embarking on a plan to speed up restructuring efforts that will hit two of its manufacturing plants hard. The new strategy, which executives said they’re starting “shortly,” will impact 740 jobs. Endo plans to close a site in Charlotte, NC, and reduce its employee base in Huntsville, AL, as it battles pressure from “new competitive entrants; … greater than expected price erosion across the generics sector; and delays on regulatory actions related to certain Endo products,” CEO …


What brings patients to pharma websites? #leading #pharmaceutical #companies #2013

Posted On Nov 16 2017 by

#pharma websites # Digital intelligence blog What brings patients to pharma websites? US survey finds doctor recommendations are key for industry site traffic The biggest influence on whether US patients visit a pharmaceutical company’s disease information or ‘drug.com’ website is whether their doctor thinks it’s worthwhile. That’s according to a US survey on how people access online health information, which found physician recommendations were the top influence on traffic to pharma websites. Makovsky’s third annual survey found that on average US patients visit a doctor three times a year, but spend nearly 52 hours searching online for health information – …


Novartis splits drugs business into two, pharma chief to leave #pharmaceutical #conference

Posted On Nov 16 2017 by

#novartis pharma # Novartis splits drugs business into two, pharma chief to leave By John Miller and Ben Hirschler | ZURICH/LONDON ZURICH/LONDON (Reuters) – Novartis is splitting its pharmaceuticals division into two business units, one focused on cancer and the second on other drugs, while switching out its current pharma head in the second high-profile management reshuffle this year. David Epstein, the American head of Novartis Pharmaceuticals and a 27-year veteran with the group, will leave the company to “explore new challenges from the U.S.”, Novartis said. Epstein’s re-location to the United States implies he is not in the running …


What the Latest FTC Guidelines Mean to Pharma Marketers #naveh #pharma

Posted On Nov 16 2017 by

#pharma guidelines # What the Latest FTC Guidelines Mean to Pharma Marketers As pharma marketers, we tend to listen closely when the U.S. Food and Drug Administration (FDA) issues guidance, such as their draft guidance on correcting misinformation online. and user-generated content. In June this year, however, it was guidelines from the Federal Trade Commission (FTC) that got our attention. The updates published via the agency s frequently asked questions and social media marketing guidelines focus primarily on testimonials and endorsements. With the rise in popularity of product reviews, the FTC is interested in ensuring consumers can clearly tell the …


Pharmaceutical Purified Water Newsletter» – N° 4 to 7 – METTLER TOLEDO #mylan #pharma

Posted On Nov 16 2017 by

#pharma newsletter # «Pharmaceutical Purified Water Newsletter» – N° 4 to 7 Perspectives in Pure Water Analytics Below to this section you can find all available «Pharmaceutical Purified Water News» in English for download in pdf-format. The newest release will always be placed on the bottom of the page. For more information on our pure water analytics solutions within the pharmaceutical USP industry, you can contact us by using the feedback button on the bottom of this page. We will be happy to assist you! «Pharmaceutical Purified Water News» N° 4 (12/04) – Headlines: Simplicity, the key to C lean-I …


Our Services to the Pharmaceuticals and Life Sciences Industry, PwC Canada #pharma #marketing #strategies

Posted On Nov 16 2017 by

#pharmaceutical companies in canada # Pharmaceuticals and Life Sciences Helping the business of health by improving the health of business Is it any surprise that Canada’s life sciences and pharmaceutical industry receives one out of every four dollars of venture capital investment? After all, an aging Canadian population has significantly increased demand for health-related products and treatment, and the sector is working hard to keep up. With the global pharmaceutical market predicted to double to $1.8 trillion by 2020, there is a lot at stake for Canadian players in this sector. Yet there are unique challenges facing our life sciences …


Contract Manufacturing Organizations (CMO) of Increasing Importance to Global Pharmaceutical Companies #galapagos #pharma

Posted On Nov 15 2017 by

#contract pharmaceutical companies # Contract Manufacturing Organizations (CMO) of Increasing Importance to Global Pharmaceutical Companies February 29, 2016 54 отметки «Нравится» 5 комментариев The pharmaceutical marketplace has changed dramatically over the last few years as pharmaceutical companies are moving from centralized, internal production to single-source providers or Contract Manufacturing Organizations (CMO). The principal reason behind this evolution in the landscape is simple to cut costs, increase capacity and reduce time-to-market. Beyond these obvious criteria there are numerous other reasons why pharmaceutical companies are relying heavily on the growing CMO market. Whereas CMOs once produced primary packaging they now offer a …